North Star Investment Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.26M | Sell |
10,703
-19
| -0.2% | -$10.3K | 0.32% | 64 |
|
|
2025
Q4 | $6.21M | Buy |
10,722
+298
| +3% | +$169K | 0.39% | 54 |
|
|
2025
Q3 | $5.06M | Hold |
10,424
| – | – | 0.32% | 67 |
|
|
2025
Q2 | $4.23M | Sell |
10,424
-30
| -0.3% | -$12.5K | 0.29% | 79 |
|
|
2025
Q1 | $5.2M | Hold |
10,454
| – | – | 0.38% | 53 |
|
|
2024
Q4 | $5.44M | Sell |
10,454
-21
| -0.2% | -$11.5K | 0.38% | 60 |
|
|
2024
Q3 | $6.48M | Sell |
10,475
-99
| -0.9% | -$58.6K | 0.45% | 56 |
|
|
2024
Q2 | $5.85M | Sell |
10,574
-280
| -3% | -$160K | 0.43% | 58 |
|
|
2024
Q1 | $6.31M | Buy |
10,854
+280
| +3% | +$157K | 0.45% | 54 |
|
|
2023
Q4 | $5.61M | Hold |
10,574
| – | – | 0.43% | 53 |
|
|
2023
Q3 | $5.35M | Sell |
10,574
-15
| -0.1% | -$7.99K | 0.45% | 54 |
|
|
2023
Q2 | $5.52M | Sell |
10,589
-10
| -0.1% | -$5.4K | 0.45% | 52 |
|
|
2023
Q1 | $6.11M | Buy |
10,599
+6,492
| +158% | +$3.66M | 0.5% | 46 |
|
|
2022
Q4 | $2.26M | Buy |
4,107
+11
| +0.3% | +$5.83K | 0.2% | 122 |
|
|
2022
Q3 | $2.08M | Sell |
4,096
-31
| -0.8% | -$17.3K | 0.2% | 118 |
|
|
2022
Q2 | $2.24M | Hold |
4,127
| – | – | 0.2% | 122 |
|
|
2022
Q1 | $2.44M | Sell |
4,127
-4
| -0.1% | -$2.3K | 0.19% | 127 |
|
|
2021
Q4 | $2.76M | Buy |
4,131
+4
| +0.1% | +$2.5K | 0.19% | 115 |
|
|
2021
Q3 | $2.36M | Hold |
4,127
| – | – | 0.19% | 126 |
|
|
2021
Q2 | $2.08M | Buy |
4,127
+60
| +1% | +$28.3K | 0.17% | 139 |
|
|
2021
Q1 | $1.86M | Hold |
4,067
| – | – | 0.18% | 141 |
|
|
2020
Q4 | $1.89M | Sell |
4,067
-5
| -0.1% | -$2.34K | 0.2% | 126 |
|
|
2020
Q3 | $1.8M | Buy |
4,072
+90
| +2% | +$37.2K | 0.21% | 110 |
|
|
2020
Q2 | $1.44M | Buy |
3,982
+115
| +3% | +$38.5K | 0.19% | 130 |
|
|
2020
Q1 | $1.1M | Buy |
3,867
+545
| +16% | +$172K | 0.16% | 152 |
|
|
2019
Q4 | $1.08M | Hold |
3,322
| – | – | 0.11% | 199 |
|
|
2019
Q3 | $968K | Buy |
3,322
+22
| +0.7% | +$6.3K | 0.11% | 207 |
|
|
2019
Q2 | $969K | Hold |
3,300
| – | – | 0.11% | 210 |
|
|
2019
Q1 | $903K | Hold |
3,300
| – | – | 0.11% | 221 |
|
|
2018
Q4 | $739K | Hold |
3,300
| – | – | 0.1% | 220 |
|
|
2018
Q3 | $805K | Hold |
3,300
| – | – | 0.09% | 229 |
|
|
2018
Q2 | $684K | Hold |
3,300
| – | – | 0.08% | 238 |
|
|
2018
Q1 | $681K | Buy |
3,300
+2,000
| +154% | +$420K | 0.08% | 234 |
|
|
2017
Q4 | $247K | Hold |
1,300
| – | – | 0.03% | 328 |
|
|
2017
Q3 | $246K | Hold |
1,300
| – | – | 0.03% | 327 |
|
|
2017
Q2 | $227K | Hold |
1,300
| – | – | 0.03% | 333 |
|
|
2017
Q1 | $200K | Hold |
1,300
| – | – | 0.03% | 340 |
|
|
2016
Q4 | $183K | Buy |
+1,300
| New | +$192K | 0.03% | 335 |
|
Other funds holding TMO
VCM
North Star Investment Management's TMO Position: Q1 2026 in Review
North Star Investment Management reduced its Thermo Fisher Scientific (TMO) stake by 0.18% in Q1 2026, selling an estimated $10.3K and leaving 10,703 shares worth $5.26M. The position accounts for 0.32% of the portfolio, ranked #64.
North Star Investment Management first reported a position in TMO in Q4 2016 and has held it in 38 quarters since. The position peaked at $6.48M in Q3 2024. 2,589 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- North Star Investment Management held 10,703 shares of Thermo Fisher Scientific worth $5.26M as of Q1 2026.
- North Star Investment Management sold 19 Thermo Fisher Scientific shares in Q1 2026, an estimated $10.3K.
- Thermo Fisher Scientific made up 0.32% of North Star Investment Management's portfolio in Q1 2026, its #64 holding.
- North Star Investment Management first reported a position in Thermo Fisher Scientific in Q4 2016 and has held it in 38 quarters since.
- North Star Investment Management's Thermo Fisher Scientific position peaked at $6.48M in Q3 2024.
- 2,589 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on North Star Investment Management's 13F filing for Q1 2026, filed 23 Apr 2026.